OXT and schizophrenia: Feifel et al. conducted a clinical proof-of-concept study of the therapeutic potential of oxytocin, administering 40 IU of intranasal oxytocin twice daily for three weeks to schizophrenia patients, and reported that oxytocin significantly reduced the Positive and Negative Symptoms Scale (PANSS) positive subscale scores [121].